| Market Cap | ₹9,346Cr |
| ROE | 42.11% |
| P/E Ratio(TTM) | 23.59 |
| EPS(TTM) | 172.04 |
| P/B Ratio | 10.86 |
| Dividend Yield | 2.88% |
| Industry P/E | 32.43 |
| Book Value | 373.70 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Managing Director | Mr. Rodolfo Hrosz |
| Founded | 1956 |
| NSE Symbol | SANOFI |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 38.33 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 40.25 | ||
| Pfizer | NA (0.00%) | 25.43 | ||
| Astrazeneca Pharma India | NA (0.00%) | 103.56 |